SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-013483
Filing Date
2023-08-07
Accepted
2023-08-07 07:02:19
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plx-20230630x10q.htm   iXBRL 10-Q 1184744
2 EX-3.6 plx-20230630xex3d6.htm EX-3.6 10366
3 EX-10.1 plx-20230630xex10d1.htm EX-10.1 198444
4 EX-31.1 plx-20230630xex31d1.htm EX-31.1 10028
5 EX-31.2 plx-20230630xex31d2.htm EX-31.2 10388
6 EX-32.1 plx-20230630xex32d1.htm EX-32.1 6121
7 EX-32.2 plx-20230630xex32d2.htm EX-32.2 6147
8 GRAPHIC plx-20230630x10q005.jpg GRAPHIC 113571
9 GRAPHIC plx-20230630x10q006.jpg GRAPHIC 100730
10 GRAPHIC plx-20230630x10q007.jpg GRAPHIC 53965
  Complete submission text file 0001558370-23-013483.txt   5227371

Data Files

Seq Description Document Type Size
11 EX-101.SCH plx-20230630.xsd EX-101.SCH 33517
12 EX-101.CAL plx-20230630_cal.xml EX-101.CAL 43074
13 EX-101.DEF plx-20230630_def.xml EX-101.DEF 116130
14 EX-101.LAB plx-20230630_lab.xml EX-101.LAB 221781
15 EX-101.PRE plx-20230630_pre.xml EX-101.PRE 194927
49 EXTRACTED XBRL INSTANCE DOCUMENT plx-20230630x10q_htm.xml XML 612058
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33357 | Film No.: 231145557
SIC: 2836 Biological Products, (No Diagnostic Substances)